These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 19690463)
1. Cancer epigenetics and biology symposium: Barcelona, May 28-29, 2009. Rattner BP Epigenetics; 2009 Aug; 4(6):421-4. PubMed ID: 19690463 [No Abstract] [Full Text] [Related]
2. [Cancer epigenetics]. Si LS Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):302-5. PubMed ID: 16777005 [No Abstract] [Full Text] [Related]
3. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets. Herranz M; Esteller M Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706 [TBL] [Abstract][Full Text] [Related]
4. [Targeted epigenetic therapy of cancer. Achievements and perspectives]. Valdespino-Gómez VM; Valdespino-Castillo VE Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455 [TBL] [Abstract][Full Text] [Related]
6. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications. Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893 [TBL] [Abstract][Full Text] [Related]
7. Unraveling the epigenetic code of cancer for therapy. Smith LT; Otterson GA; Plass C Trends Genet; 2007 Sep; 23(9):449-56. PubMed ID: 17681396 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic alternations and cancer chemotherapy response. Lv JF; Hu L; Zhuo W; Zhang CM; Zhou HH; Fan L Cancer Chemother Pharmacol; 2016 Apr; 77(4):673-84. PubMed ID: 26707728 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic Targets and their Inhibitors in Cancer Therapy. Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481 [TBL] [Abstract][Full Text] [Related]
11. First Barcelona Conference on Epigenetics and Cancer. Palau A; Perucho M; Esteller M; Buschbeck M Epigenetics; 2014 Mar; 9(3):468-75. PubMed ID: 24413145 [TBL] [Abstract][Full Text] [Related]
12. Histone deacetylation in epigenetics: an attractive target for anticancer therapy. Mai A; Massa S; Rotili D; Cerbara I; Valente S; Pezzi R; Simeoni S; Ragno R Med Res Rev; 2005 May; 25(3):261-309. PubMed ID: 15717297 [TBL] [Abstract][Full Text] [Related]
13. Novel approaches on epigenetics. Papait R; Monti E; Bonapace IM Curr Opin Drug Discov Devel; 2009 Mar; 12(2):264-75. PubMed ID: 19333872 [TBL] [Abstract][Full Text] [Related]
14. Barcelona Conference on Epigenetics and Cancer: 50 years of histone acetylation. Perez-Salvia M; Simó-Riudalbas L; Ausió J; Esteller M Epigenetics; 2015; 10(5):446-51. PubMed ID: 25942103 [TBL] [Abstract][Full Text] [Related]
15. Translational epigenetics: clinical approaches to epigenome therapeutics for cancer. Selcuklu SD; Spillane C Epigenetics; 2008; 3(2):107-12. PubMed ID: 18437050 [TBL] [Abstract][Full Text] [Related]
16. Presenting the epigenome roadmap. Skipper M; Eccleston A; Gray N; Heemels T; Le Bot N; Marte B; Weiss U Nature; 2015 Feb; 518(7539):313. PubMed ID: 25693561 [No Abstract] [Full Text] [Related]
17. Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2. Christofides A; Karantanos T; Bardhan K; Boussiotis VA Oncotarget; 2016 Dec; 7(51):85624-85640. PubMed ID: 27793053 [TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitor and demethylating agent chromatin compaction and the radiation response by cancer cells. Bar-Sela G; Jacobs KM; Gius D Cancer J; 2007; 13(1):65-9. PubMed ID: 17464248 [TBL] [Abstract][Full Text] [Related]